Meningitis Vaccines Market, By Type (Bivalent, Quadrivalent, and Others), By Brand (MenQuadfi, Menveo, Trumenba, Bexsero, and Others), By Serotype (Serotype A, Serotype B, Serotype C, Serotype W-135, and Others), By Sales Channel (Private and Public), By

Meningitis Vaccines Market, By Type (Bivalent, Quadrivalent, and Others), By Brand (MenQuadfi, Menveo, Trumenba, Bexsero, and Others), By Serotype (Serotype A, Serotype B, Serotype C, Serotype W-135, and Others), By Sales Channel (Private and Public), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)


Meningitis is a potentially fatal inflammation of the protective membranes covering the brain and spinal cord known as meninges. It can be caused by various pathogens such as bacteria, viruses, parasites, and fungi. The most common causes of meningitis are viral and bacterial infections. Bacterial infections including those caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b can rapidly lead to serious illness and even death if not treated promptly with appropriate antibiotics. While timely treatment with antibiotics can cure most cases of bacterial meningitis, the infection may still lead to long-term disability in 10-15% of cases such as hearing loss, neurodevelopmental delay, and epilepsy or limb amputations. To prevent the occurrence of invasive meningococcal disease caused by N. meningitidis, vaccination is recommended. Meningococcal conjugate vaccines have been created to provide both direct protection and herd immunity, effectively controlling the spread of the disease within communities.

Market Dynamics

Global meningitis vaccines market growth is primarily driven by increasing burden of invasive meningococcal disease and implementation of large-scale immunization programs worldwide. For instance, as per the data published by the World Health Organization (WHO) in 2021, meningitis causes approximately 250,000–500,000 cases annually resulting in over 30,000 deaths, making it a public health priority. Evolving epidemiology of common pathogenic serogroups causing outbreaks, recommendations for routine immunization by national regulatory bodies and availability of vaccine combinations are expected to create robust growth opportunities in the market during the forecast period. However, factors such as high costs associated with the manufacturing and development of novel vaccines, vaccine stockouts during outbreaks, and lack of awareness in low and middle-income countries can hamper the market growth. Development of affordable multivalent vaccines covering emerging serotypes and expansion of immunization programs in developing nations present lucrative opportunities for player engagement and further market expansion.

Key Features of the Study
  • This report provides in-depth analysis of the global meningitis vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global meningitis vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., Sanofi, GSK plc., Serum Institute of India Ltd., Merck & co., Inc., Walvax Biotechnology Co., Ltd., Icepta Pharmaceuticals Ltd., and Hualan Biological Engineering Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Market Segmentation
  • Type Insights
  • Bivalent
  • Quadrivalent
  • Others
  • Brand Insights
  • MenQuadfi
  • Menveo
  • Trumenba
  • Bexsero
  • Others
  • Age Group Insights
  • Infants
  • Adults
  • Serotype Insights
  • Serotype A
  • Serotype B
  • Serotype C
  • Serotype W-135
  • Others
  • Sales Channel Insights
  • Private
  • Public
  • Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Pfizer Inc.
  • Sanofi
  • GSK plc.
  • Serum Institute of India Ltd.
  • Merck & co., Inc.
  • Walvax Biotechnology Co., Ltd.
  • Icepta Pharmaceuticals Ltd.
  • Hualan Biological Engineering Inc.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Meningitis Vaccines Market, By Type
Meningitis Vaccines Market, By Brand
Meningitis Vaccines Market, By Age Group
Meningitis Vaccines Market, By Serotype
Meningitis Vaccines Market, By Sales Channel
Meningitis Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Epidemiology
4. Meningitis Vaccines Market, By Type, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Bivalent
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Quadrivalent
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Meningitis Vaccines Market, By Brand, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
MenQuadfi
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Menveo
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Trumenba
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Bexsero
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Meningitis Vaccines Market, By Age Group, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Infants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Meningitis Vaccines Market, By Serotype, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Serotype A
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype B
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype C
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype W-135
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Meningitis Vaccines Market, By Sales Channel, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Private
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Public
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Meningitis Vaccines Market, By Region, 2019 - 2031, (USD Bn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, Country/Region, 2019 - 2031, (USD Bn)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GSK plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Serum Institute of India Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Walvax Biotechnology Co., Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Icepta Pharmaceuticals Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hualan Biological Engineering Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us
*Browse 36 market data tables and 32 figures on 'Meningitis Vaccines Market' - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings